2m 2m 2m 2m 2m 2m 2m
Vanda Pharma (VNDA)
NASDAQ
$3.85-$0.16 (-3.99%)
Price as of Oct 22, 2026 7:30 PM EDT- $242.5MMarket Cap
- -24.91%1-Year Change
- BiotechnologyIndustry
Vanda Pharma (VNDA)
$3.85-$0.16 (-3.99%)
VNDA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.01 | ||
Change | -$0.16 (-3.84%) | ||
Open | $4.18 | ||
High | $4.18 | ||
Low | $3.96 | ||
Previous Close | $4.17 | ||
Volume | 1,087,843 | ||
30-Day Average Volume | 1,105,547 | ||
1-Week Change | -4.98% | ||
1-Month Change | -22.21% | ||
1-Year Change | -24.91% | ||
3-Year Change | -7.60% | ||
5-Year Change | -77.77% | ||
Fundamentals | |||
Shares Outstanding | 60.5M | ||
Total Assets | $412.5M | ||
Market Cap | $242.5M | ||
Enterprise Value | $186.6M | ||
Period: QTR TTM FY | |||
Revenue | $50.5M | ||
Net Income | -$62.5M | ||
Free Cash Flow | -$31.3M | ||
EBIT | -$62.4M | ||
EBITDA | -$60.4M | ||
Net Working Capital | $100.5M | ||
EPS | -$1.04 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | 4 | ||
P/B | 1 | ||
P/E | -4 | ||
PEG | 0 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue